Stay updated with breaking news from Adagene. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
- Total potential transaction value of $2.5 billion plus royalties - SAN DIEGO and SUZHOU, China, March 02, 2022 -- Adagene Inc. , a company transforming the discovery and... | March 2, 2022
SAN DIEGO and SUZHOU, China, Jan. 27, 2022 -- Adagene Inc. , a company transforming the discovery and development of novel antibody-based therapies, today announced the first patient has been... | January 27, 2022
- Dr. Gandara, Professor and Senior Advisor to the Thoracic Oncology Program at University of California Davis, brings deep expertise and strategic vision...
- Phase 1b/2 trial to be conducted at the National University Cancer Institute, Singapore and the National Cancer Centre Singapore, in Collaboration with...